文献速递糖尿病性腺与生殖内分泌肥胖与代谢综合征

肥胖对多囊卵巢综合征女性2型糖尿病发病率的影响

The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.
PubMed 文献 · Diabetes Care · 2019-01-31

基于澳大利亚女性健康纵向研究2000-2015年数据,分析18-42岁女性中多囊卵巢综合征(PCOS)与2型糖尿病的关系。随访1,919人年期间186例新发2型糖尿病,PCOS组发病率4.19/1,000人年显著高于对照组的1.02/1,000人年。调整BMI等因素后PCOS仍是2型糖尿病最强预测因素之一(HR 3.23,95%CI 2.07-5.05,P<0.001),且该风险独立于年龄和BMI。

要点

  • PCOS女性2型糖尿病风险显著增高,且独立于年龄和BMI
  • 随肥胖程度增加,2型糖尿病发病率显著上升
  • PCOS在瘦型女性中带来的相对风险更大

核心结论

  • PCOS女性2型糖尿病风险增高,且独立于年龄和BMI。
  • 2型糖尿病发病率随肥胖程度显著增加,但PCOS在瘦型女性中相对风险更大。
  • 基于中等绝对临床风险,指南建议所有PCOS女性每1-3年筛查2型糖尿病。

研究设计与样本

  • 基于澳大利亚女性健康纵向研究(ALSWH)2000-2015年数据库。
  • 采用人时和生存分析估计18-42岁女性2型糖尿病的全国发病率和预测因素。
  • 随访共1,919人年,186名女性发生2型糖尿病。

主要发现

  • PCOS组2型糖尿病发病率为4.19/1,000人年,对照组为1.02/1,000人年(P<0.001)。
  • 在健康体重、超重和肥胖亚组中,2型糖尿病发病率分别为3.21、4.67和8.80,PCOS组与年龄匹配对照组的发病率比分别为4.68、3.52和2.36(P<0.005)。
  • 调整BMI、教育、居住地区和2型糖尿病家族史后,PCOS是全队列中最有影响力的2型糖尿病预测因素之一(HR 3.23,95%CI 2.07-5.05,P<0.001)。

关键数值与推荐

  • 指南推荐所有PCOS女性每1-3年筛查2型糖尿病,涵盖所有BMI类别和年龄范围。
  • 筛查频率受额外2型糖尿病风险因素影响。

临床怎么用

  • 对PCOS女性应常规评估2型糖尿病风险,不论体重和年龄。
  • 瘦型PCOS女性也应重视2型糖尿病筛查,因其相对风险更高。
  • 根据额外风险因素调整筛查频率,建议每1-3年筛查一次。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The nature of the independent relationship between polycystic ovary syndrome (PCOS) and type 2 diabetes remains unclear. Few studies have aimed to clarify this relationship independent of obesity in longitudinal population-based cohorts. RESEARCH DESIGN AND METHODS: We used the Australian Longitudinal Study on Women's Health (ALSWH) (2000-2015) database to estimate nationwide incidence rates and predictors of type 2 diabetes among women aged 18-42 using person-time and survival analysis. RESULTS: Over a follow-up of 1,919 person-years (PYs), 186 women developed type 2 diabetes. The incidence rate was 4.19/1,000 PYs and 1.02/1,000 PYs (P < 0.001) in PCOS and control subjects. On subgroup analyses across healthy-weight, overweight, and obese categories of women, the incidence rates for type 2 diabetes were 3.21, 4.67, and 8.80, whereas incidence rate ratios were 4.68, 3.52, and 2.36 (P < 0.005) in PCOS versus age-matched control subjects. PCOS was one of the most influential predictors for type 2 diabetes in the entire cohort (hazard ratio 3.23, 95% CI 2.07-5.05, P < 0.001) adjusting for BMI, education, area of residence, and family history of type 2 diabetes. CONCLUSIONS: Women with PCOS are at an increased risk of type 2 diabetes, irrespective of age and BMI. The incidence of type 2 diabetes increases substantially with increasing obesity; yet, PCOS adds a greater relative risk in lean women. Based on the overall moderate absolute clinical risk demonstrated here, guideline recommendations suggest type 2 diabetes screening every 1-3 years in all women with PCOS, across BMI categories and age ranges, with frequency influenced by additional type 2 diabetes risk factors.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kakoly NS, Earnest A, Teede HJ, et al. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome. Diabetes Care. 2019. PMID: 30705063. doi:10.2337/dc18-1738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。